Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 (Q113889528)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 |
clinical trial |
Statements
NEBUHEPA (English)
0 references
Efficacy and Safety Study to Evaluate the Use of Nebulized Heparin in Patients With Severe Acute Respiratory Syndrome Covid-19 (SARS-CoV-2) (English)
0 references
1 June 2020
0 references
30 October 2020
0 references
200
0 references
18 year
0 references
100 year
0 references